Tetraphase (TTPH) Prices 10.7M IPO at $7/Share
Tweet Send to a Friend
Tetraphase Pharmaceuticals, Inc. (Nasdaq: TTPH) today announced the pricing of its initial public offering of 10,714,286 shares of common stock at a price to the public of $7.00 per share, less underwriting discounts and commissions. Tetraphase’s common stock is expected to begin trading on the NASDAQ Global Market under the symbol “TTPH” on March 20, 2013.
Tetraphase has granted the underwriters a 30-day option to purchase up to 1,607,143 additional shares of common stock at the same price to cover over allotments, if any.
Barclays and BMO Capital Markets are acting as joint book-running managers. Stifel, JMP Securities and Needham & Company are acting as co-managers for the offering.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Tetraphase has granted the underwriters a 30-day option to purchase up to 1,607,143 additional shares of common stock at the same price to cover over allotments, if any.
Barclays and BMO Capital Markets are acting as joint book-running managers. Stifel, JMP Securities and Needham & Company are acting as co-managers for the offering.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Tetraphase Pharmaceuticals to Present at the Annual UBS Global Healthcare Conference
- Tableau Software (DATA) IPO now indicated $45-$48
- Marketo (MKTO) IPO Opens 54% Higher
Create E-mail Alert Related Categories
IPOs, Trading HaltsRelated Entities
Needham & Company, BMO Capital, JMP Securities, Barclays
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
